Norge -
norsk -
Statens legemiddelverk
adartrel 0.25 mg
glaxosmithkline as - ropinirolhydroklorid - tablett, filmdrasjert - 0.25 mg
Norge -
norsk -
Statens legemiddelverk
adartrel 2 mg
glaxosmithkline as - ropinirolhydroklorid - tablett, filmdrasjert - 2 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
delstrigo
merck sharp & dohme b.v. - doravirine, lamivudine, tenofovir disoproxil fumarate - hiv-infeksjoner - antivirale midler til behandling av hiv-infeksjoner, kombinasjoner - delstrigo er indisert for behandling av voksne smittet med hiv-1 uten tidligere eller nåværende bevis for motstand mot nnrti klasse, lamivudine, eller tenofovir. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.
Norge -
norsk -
Statens legemiddelverk
dronedaron aristo 400 mg
aristo pharma gmbh - dronedaronhydroklorid - tablett, filmdrasjert - 400 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinal stromal tumors - antineoplastiske midler - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.
Norge -
norsk -
Statens legemiddelverk
almogran 12.5 mg
almirall, s.a. - almotriptanmalat - tablett, filmdrasjert - 12.5 mg